By clicking “View Open Positions”, you acknowledge and consent to your personal information being transferred cross-border to Pivotal Headquarters in Hong Kong. For more details, please refer to the Recruitment Privacy Policy.
David Malek
Venture Partner – Pivotal bioVenture Partners (US)
LOCATION
San Francisco
FOCUS AREA
Venture Capital
David joined Pivotal Life Sciences in 2018. Prior to joining Pivotal he was the Chief Business Officer at BioLineRx (NASDAQ: BLRX), a drug development company, where he established partnerships with Novartis, Roche/Genentech and Merck and was involved in raising over $100 million. Prior to that David held a variety of leadership roles at Sanofi (NASDAQ: SNY), mainly in corporate and business development functions. David serves on the board of directors of Avalyn Pharma, aptihealth and Encodia. David earned his MBA at the Tuck School of Business at Dartmouth, and his B.A. in Statistics from the University of Haifa.
SHANGHAI
Suite 2001, YI FUNG PLACE
99 West Ziyun Road
Changning District
Shanghai 200051, China
HONG KONG
17th Floor
AIRSIDE
2 Concorde Road, Kai Tak
Hong Kong SAR
SAN FRANCISCO
501 2nd Street, Suite 200
San Francisco, CA 94107
United States
中文
English
